Activist investor Carl Icahn said he is hopeful more potential buyers will surface for Family Dollar.» Read More
CNBC's Jim Cramer explains why Apple's buyback of $14 billion of its stock reminds him of Clint Eastwood's Dirty Harry movie character.
BOSTON/ NEW YORK, Feb 6- In the past, billionaire investor Daniel Loeb would often wait for an industry conference before revealing his investment ideas. Such announcements-- including Loeb's bet on Dow Chemicals and Kyle Bass' bet on General Motors-- often lead to big swings in share prices as other investors pile on.
Under intense pressure from activist investor Carl Icahn to up that $60 billion by another $50 billion, Apple last week beat earnings and revenue estimates but managed to disappoint the market anyway, sparking a double-digit percent sell-off in its shares.
As Apple's annual meeting approaches, some big investors are fighting an increasingly public fight over what the company should do with its cash.
CalPERS and Carl Icahn are fighting over Apple's buyback program. CNBC's Josh Lipton provides all the details.
Discussing the role of the activist investor, and a new organization created to push back against them, with 25-year Vanguard veteran Glenn Booraem.
James Woolery, Cadwalader, Wickersham & Taft, and Declan Kelly, Teneo Strategy CEO, discuss how some executives are protecting their companies from activist investors.
Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit as it sold more 3 D systems that help detect breast cancer, and its CEO said he would pursue the strategic review started by his predecessor.
Feb 3- Medical device maker Hologic Inc reported a better-than-expected adjusted quarterly profit in part due to higher sales of its 3 D digital mammography systems. Hologic shares rose 4 percent in extended trading.
*Ackman raises questions about Herbalife distributors. Feb 3- Herbalife Ltd estimated fourth-quarter profit and sales above market forecasts on Monday, but investor William Ackman quickly struck back with claims about a former top Herbalife distributor, raising new questions about the company's sales practices.
Feb 3- Herbalife Ltd estimated fourth-quarter profit and sales above market forecasts, dealing a setback to investor William Ackman who has accused the nutrition and weight loss company of being a pyramid scheme and taken a big short position on the stock.
Feb 3- Nutrition and weight loss company Herbalife Ltd estimated fourth-quarter profit and sales above analysts' expectations, sending its up 4 percent in premarket trading.
Carl Icahn has been pushing Apple to use its $150 billion war chest to buy back company shares. Not every shareholder agrees.
Apple's numbers are remarkable, but there's not much growth there, says Ken Allen of T. Rowe Price, weighing in on the tech giant's outlook. Allen also shares his top tech picks, including the play on Google and Red Hat.
CNBC's Scott Wapner reports activist investor Carl Icahn says the dip in Apple's stock price is "completely misinterpreted" and says the long-term picture remains unchanged.
Activist investor Carl Icahn bought more Apple shares Tuesday, as the stock plunged after an iPhone sales number that disappointed Wall Street.
It's now Tim Cook versus Wall Street, according to CNBC's Jim Cramer.
The "Squawk on the Street" news team discuss Apple's expected fiscal Q1 earnings, the Carl Icahn influence and Chinese markets.
Saturday marks one year since Carl Icahn and Bill Ackman brawled on "Fast Money Halftime Report" over Herbalife. The FMHR traders discuss news Sen. Ed Markey (D-MA) is launching an investigation into Herbalife.
In an open letter to Apple shareholders, investor Carl Icahn says Apple is the most overcapitalized company in corporate history. CNBC's Dominic Chu details the letter's specifics.